HuagongsheHuagongshe Chemistry Print Report · For research reference only
Sodium hydride → 4,9-Dihydro-9-(3-dimethylaminopropyl)-4-methyl-10H-thieno[3,4-b][1,5]benzodiazepin-10-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | 3-Chloro-N,N-dimethyl-1-propanamine | HCID 66960 | — |
| Reactant | 4,9-Dihydro-4-methyl-10H-thieno[3,4-b][1,5]benzodiazepin-10-one | HCID 12521642 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 4,9-Dihydro-9-(3-dimethylaminopropyl)-4-methyl-10H-thieno[3,4-b][1,5]benzodiazepin-10-one | HCID 21455234 | — |
Reaction Steps
A mixture of 0.3 g. of 55% sodium hydride-mineral oil dispersion and 0.35 g. of 4,9-dihydro-4-methyl-10H-thieno-[3,4-b][1,5]benzodiazepin-10-one in 25 ml. of dry dimethylformamide is stirred at room temperature for 0.5 hours. To the mixture is added 0.45 g. of dimethylaminopropyl chloride and stirring at room temperature is continued for 18 hours. The reaction mixture is cooled, quenched with water, acidified, decolorized and filtered. The filtrate is made alkaline and extracted with chloroform. The dried chloroform extracts are concentrated under reduced pressure to give an oil which is crystallized by dissolving in boiling hexane and a minimal volume of ethyl acetate and cooling to give off-white crystals, m.p. 52°-56° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US04007272 |
| Source dataset | uspto-grants-1977_02 |
| ORD ID | ord-303f42ecf635484681fd45d15d6b92dc |
| Source note | uspto-grants-1977_02 |